{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:15:35Z","timestamp":1778526935517,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":74,"publisher":"Springer US","isbn-type":[{"value":"9781071625729","type":"print"},{"value":"9781071625736","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2573-6_18","type":"book-chapter","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T16:06:13Z","timestamp":1662480373000},"page":"505-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Pharmacogenomics in Postoperative Pain Management"],"prefix":"10.1007","author":[{"given":"E. Paylor","family":"Sachtleben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria L.","family":"Lassiegne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Boudreaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11912-020-0865-4","volume":"22","author":"EM Cornett","year":"2020","unstructured":"Cornett EM, Carroll Turpin MA, Pinner A et al (2020) Pharmacogenomics of pain management: the impact of specific biological polymorphisms on drugs and metabolism. Curr Oncol Rep 22:18","journal-title":"Curr Oncol Rep"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/PGPM.S179152","volume":"12","author":"AD Kaye","year":"2019","unstructured":"Kaye AD, Garcia AJ, Hall OM et al (2019) Update on the pharmacogenomics of pain management. PGPM 12:125\u2013143","journal-title":"PGPM"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bpa.2020.05.008","volume":"34","author":"R Chaturvedi","year":"2020","unstructured":"Chaturvedi R, Alexander B, A\u2019Court AM et al (2020) Genomics testing and personalized medicine in the preoperative setting: can it change outcomes in postoperative pain management? Best Pract Res Clin Anaesthesiol 34:283\u2013295","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"18_CR4","first-page":"229","volume":"88","author":"EN Aroke","year":"2020","unstructured":"Aroke EN, Kittelsrud JM (2020) Pharmacogenetics of postoperative pain management: a review. AANA J 88:229\u2013236","journal-title":"AANA J"},{"key":"18_CR5","unstructured":"Nurse Anesthesiology (2020) A primer to pharmacogenetics of postoperative pain management. Available from: https:\/\/nurseanesthesiology.aana.com\/a-primer-to-pharmacogenetics-of-postoperative-pain-management"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","volume":"16","author":"RL Nahin","year":"2015","unstructured":"Nahin RL (2015) Estimates of pain prevalence and severity in adults: United States, 2012. J Pain 16:769\u2013780","journal-title":"J Pain"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0277-9536(01)00018-1","volume":"54","author":"M Brekke","year":"2002","unstructured":"Brekke M, Hjortdahl P, Kvien TK (2002) Severity of musculoskeletal pain: relations to socioeconomic inequality. Soc Sci Med 54:221\u2013228","journal-title":"Soc Sci Med"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.psyneuen.2015.09.018","volume":"63","author":"S Fischer","year":"2016","unstructured":"Fischer S, Doerr JM, Strahler J et al (2016) Stress exacerbates pain in the everyday lives of women with fibromyalgia syndrome \u2013 the role of cortisol and alpha-amylase. Psychoneuroendocrinology 63:68\u201377","journal-title":"Psychoneuroendocrinology"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.clpt.2006.01.007","volume":"79","author":"L Coulbault","year":"2006","unstructured":"Coulbault L, Beaussier M, Verstuyft C et al (2006) Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther 79:316\u2013324","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1186\/s12889-015-2414-x","volume":"15","author":"B \u00d8ster\u00e5s","year":"2015","unstructured":"\u00d8ster\u00e5s B, Sigmundsson H, Haga M (2015) Perceived stress and musculoskeletal pain are prevalent and significantly associated in adolescents: an epidemiological cross-sectional study. BMC Public Health 15:1081","journal-title":"BMC Public Health"},{"key":"18_CR11","first-page":"GC04","volume":"8","author":"S Periasamy","year":"2014","unstructured":"Periasamy S, Poovathai R, Pondiyadanar S (2014) Influences of gender on postoperative morphine consumption. J Clin Diagn Res 8:GC04\u2013GC07","journal-title":"J Clin Diagn Res"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12891-017-1597-y","volume":"18","author":"H Si","year":"2017","unstructured":"Si H, Yang T, Zeng Y et al (2017) Correlations between inflammatory cytokines, muscle damage markers and acute postoperative pain following primary total knee arthroplasty. BMC Musculoskelet Disord 18:265","journal-title":"BMC Musculoskelet Disord"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"J-M Zhang","year":"2007","unstructured":"Zhang J-M, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27\u201337","journal-title":"Int Anesthesiol Clin"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ, Robinson RL, Katon W et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433\u20132445","journal-title":"Arch Intern Med"},{"key":"18_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165316","volume":"11","author":"T-J Song","year":"2016","unstructured":"Song T-J, Cho S-J, Kim W-J et al (2016) Anxiety and depression in tension-type headache: a population-based study. PLoS One 11:e0165316","journal-title":"PLoS One"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ejpain.2008.07.003","volume":"13","author":"KA Davies","year":"2009","unstructured":"Davies KA, Silman AJ, Macfarlane GJ et al (2009) The association between neighbourhood socio-economic status and the onset of chronic widespread pain: results from the EPIFUND study. Eur J Pain 13:635\u2013640","journal-title":"Eur J Pain"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pain.2007.06.008","volume":"136","author":"CS Nielsen","year":"2008","unstructured":"Nielsen CS, Stubhaug A, Price DD et al (2008) Individual differences in pain sensitivity: genetic and environmental contributions. Pain 136:21\u201329","journal-title":"Pain"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s11999-011-1770-9","volume":"469","author":"JM Mossey","year":"2011","unstructured":"Mossey JM (2011) Defining racial and ethnic disparities in pain management. Clin Orthop Relat Res 469:1859\u20131870","journal-title":"Clin Orthop Relat Res"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1526-4637.2003.03034.x","volume":"4","author":"CR Green","year":"2003","unstructured":"Green CR, Anderson KO, Baker TA et al (2003) The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 4:277\u2013294","journal-title":"Pain Med"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpain.2006.06.002","volume":"8","author":"CC Reyes-Gibby","year":"2007","unstructured":"Reyes-Gibby CC, Aday LA, Todd KH et al (2007) Pain in aging community-dwelling adults in the United States: non-hispanic whites, non-hispanic blacks, and hispanics. J Pain 8:75\u201384","journal-title":"J Pain"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2217\/pgs.15.6","volume":"16","author":"JAG Ag\u00fandez","year":"2015","unstructured":"Ag\u00fandez JAG, Blanca M, Cornejo-Garc\u00eda JA et al (2015) Pharmacogenomics of cyclooxygenases. Pharmacogenomics 16:501\u2013522","journal-title":"Pharmacogenomics"},{"key":"18_CR22","first-page":"125","volume":"12","author":"AD Kaye","year":"2019","unstructured":"Kaye AD, Garcia AJ, Hall OM et al (2019) Update on the pharmacogenomics of pain management. Pharmgenomics Pers Med 12:125\u2013143","journal-title":"Pharmgenomics Pers Med"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cpt.1830","volume":"108","author":"KN Theken","year":"2020","unstructured":"Theken KN, Lee CR, Gong L et al (2020) Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs. Clin Pharmacol Ther 108:191\u2013200","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3727\/105221617X15084371374138","volume":"18","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran A, Jaeschke H (2018) Acetaminophen toxicity: novel insights into mechanisms and future perspectives. Gene Expr 18:19\u201330","journal-title":"Gene Expr"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.acc.2020.02.002","volume":"98","author":"LP James","year":"2020","unstructured":"James LP, McGill MR, Roberts DW et al (2020) Advances in biomarker development in acetaminophen toxicity. Adv Clin Chem 98:35\u201350","journal-title":"Adv Clin Chem"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","volume":"25","author":"LL Mazaleuskaya","year":"2015","unstructured":"Mazaleuskaya LL, Sangkuhl K, Thorn CF et al (2015) PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics 25:416\u2013426","journal-title":"Pharmacogenet Genomics"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bja.2019.06.014","volume":"123","author":"H Hermanns","year":"2019","unstructured":"Hermanns H, Hollmann MW, Stevens MF et al (2019) Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. Br J Anaesth 123:335\u2013349","journal-title":"Br J Anaesth"},{"key":"18_CR28","first-page":"959","volume":"28","author":"JS Wang","year":"2000","unstructured":"Wang JS, Backman JT, Taavitsainen P et al (2000) Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans. Drug Metab Dispos 28:959\u2013965","journal-title":"Drug Metab Dispos"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.2147\/DDDT.S152366","volume":"11","author":"P Fang","year":"2017","unstructured":"Fang P, Tang P-F, Xu R-A et al (2017) Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro. Drug Des Devel Ther 11:3503\u20133510","journal-title":"Drug Des Devel Ther"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.3390\/jpm10030065","volume":"10","author":"S Zarei","year":"2020","unstructured":"Zarei S, Costas Y, Orozco G et al (2020) A web-based pharmacogenomics search tool for precision medicine in perioperative care. J Pers Med 10:E65","journal-title":"J Pers Med"},{"issue":"4","key":"18_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cpt.2149","volume":"110","author":"KR Crews","year":"2021","unstructured":"Crews KR, Monte AA, Huddart R et al (2021) Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther 110(4):888\u2013896","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR32","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.18.00058","volume":"7","author":"ME Awad","year":"2019","unstructured":"Awad ME, Padela MT, Sayeed Z et al (2019) Pharmacogenomic testing for postoperative pain optimization before total joint arthroplasty: a focus on drug-drug-gene interaction with commonly prescribed drugs and prior opioid use. JBJS Rev 7:e2","journal-title":"JBJS Rev"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/FPC.0b013e32832b89da","volume":"19","author":"J L\u00f6tsch","year":"2009","unstructured":"L\u00f6tsch J, von Hentig N, Freynhagen R et al (2009) Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenet Genomics 19:429\u2013436","journal-title":"Pharmacogenet Genomics"},{"key":"18_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/clpt.2011.280","volume":"91","author":"J Sistonen","year":"2012","unstructured":"Sistonen J, Madadi P, Ross CJ et al (2012) Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers. Clin Pharmacol Ther 91:692\u2013699","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/aps.2016.157","volume":"38","author":"Z-Z Yang","year":"2017","unstructured":"Yang Z-Z, Li L, Wang L et al (2017) The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants. Acta Pharmacol Sin 38:1184\u20131194","journal-title":"Acta Pharmacol Sin"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejps.2016.12.039","volume":"99","author":"LM Nielsen","year":"2017","unstructured":"Nielsen LM, Sverrisd\u00f3ttir E, Stage TB et al (2017) Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics. Eur J Pharm Sci 99:337\u2013342","journal-title":"Eur J Pharm Sci"},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/bcpt.12248","volume":"115","author":"S Bastami","year":"2014","unstructured":"Bastami S, Gupta A, Zackrisson A-L et al (2014) Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption. Basic Clin Pharmacol Toxicol 115:423\u2013431","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4103\/1119-3077.269019","volume":"22","author":"M Ning","year":"2019","unstructured":"Ning M, Tao Y, Hu X et al (2019) Roles of UGT2B7 C802T gene polymorphism on the efficacy of morphine treatment on cancer pain among the Chinese han population. Niger J Clin Pract 22:1319\u20131323","journal-title":"Niger J Clin Pract"},{"key":"18_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.419","volume":"6","author":"P Haage","year":"2018","unstructured":"Haage P, Kronstrand R, Josefsson M et al (2018) Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6, CYP2B6, and CYP3A4 genotype. Pharmacol Res Perspect 6:e00419","journal-title":"Pharmacol Res Perspect"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/jpm10040198","volume":"10","author":"V Rollason","year":"2020","unstructured":"Rollason V, Lloret-Linares C, Lorenzini KI et al (2020) Evaluation of phenotypic and genotypic variations of drug metabolising enzymes and transporters in chronic pain patients facing adverse drug reactions or non-response to analgesics: a retrospective study. J Pers Med 10:198","journal-title":"J Pers Med"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2147\/DDDT.S199574","volume":"13","author":"J Lee","year":"2019","unstructured":"Lee J, Yoo H-D, Bae J-W et al (2019) Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6. Drug Des Devel Ther 13:1751\u20131761","journal-title":"Drug Des Devel Ther"},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41431-019-0369-6","volume":"27","author":"FR Wendt","year":"2019","unstructured":"Wendt FR, Novroski NMM, Rahikainen A-L et al (2019) A pathway-driven predictive model of tramadol pharmacogenetics. Eur J Hum Genet 27:1143\u20131156","journal-title":"Eur J Hum Genet"},{"key":"18_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2217\/pgs-2020-0026","volume":"21","author":"M Saiz-Rodr\u00edguez","year":"2020","unstructured":"Saiz-Rodr\u00edguez M, Ochoa D, Rom\u00e1n M et al (2020) Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics. Pharmacogenomics 21:663\u2013675","journal-title":"Pharmacogenomics"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00228-018-2527-0","volume":"74","author":"H Tanaka","year":"2018","unstructured":"Tanaka H, Naito T, Sato H et al (2018) Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. Eur J Clin Pharmacol 74:1461\u20131469","journal-title":"Eur J Clin Pharmacol"},{"key":"18_CR45","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1097\/j.pain.0000000000000662","volume":"157","author":"UM Stamer","year":"2016","unstructured":"Stamer UM, Musshoff F, St\u00fcber F et al (2016) Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption. Pain 157:2467\u20132475","journal-title":"Pain"},{"key":"18_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/AJP.0000000000000654","volume":"35","author":"L Wang","year":"2019","unstructured":"Wang L, Wei C, Xiao F et al (2019) Influences of COMT rs4680 and OPRM1 rs1799971 polymorphisms on chronic postsurgical pain, acute pain, and analgesic consumption after elective cesarean delivery. Clin J Pain 35:31\u201336","journal-title":"Clin J Pain"},{"key":"18_CR47","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1373\/jalm.2018.026070","volume":"3","author":"K Hosseinnejad","year":"2019","unstructured":"Hosseinnejad K, Yin T, Gaskins JT et al (2019) Lack of influence by CYP3A4 and CYP3A5 genotypes on pain relief by hydrocodone in postoperative cesarean section pain management. J Appl Lab Med 3:954\u2013964","journal-title":"J Appl Lab Med"},{"key":"18_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2217\/pme-2017-0032","volume":"15","author":"DM Smith","year":"2018","unstructured":"Smith DM, Weitzel KW, Cavallari LH et al (2018) Clinical application of pharmacogenetics in pain management. Per Med 15:117\u2013126","journal-title":"Per Med"},{"key":"18_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cca.2013.11.015","volume":"429","author":"ME Stauble","year":"2014","unstructured":"Stauble ME, Moore AW, Langman LJ et al (2014) Hydrocodone in postoperative personalized pain management: pro-drug or drug? Clin Chim Acta 429:26\u201329","journal-title":"Clin Chim Acta"},{"key":"18_CR50","first-page":"E227","volume":"16","author":"MV Boswell","year":"2013","unstructured":"Boswell MV, Stauble ME, Loyd GE et al (2013) The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone. Pain Physician 16:E227\u2013E235","journal-title":"Pain Physician"},{"key":"18_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2217\/pgs-2020-0143","volume":"22","author":"NN Umukoro","year":"2021","unstructured":"Umukoro NN, Aruldhas BW, Rossos R et al (2021) Pharmacogenomics of oxycodone: a narrative literature review. Pharmacogenomics 22:275\u2013290","journal-title":"Pharmacogenomics"},{"key":"18_CR52","doi-asserted-by":"crossref","unstructured":"Huddart R, Clarke M, Altman RB et al (2018) PharmGKB summary. Pharmacogenet Genomics 28:230\u2013237","DOI":"10.1097\/FPC.0000000000000351"},{"key":"18_CR53","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","volume":"152","author":"P Klepstad","year":"2011","unstructured":"Klepstad P, Fladvad T, Skorpen F et al (2011) Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 152:1139\u20131145","journal-title":"Pain"},{"key":"18_CR54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/0091270010397729","volume":"52","author":"ST Zwisler","year":"2012","unstructured":"Zwisler ST, Enggaard TP, Mikkelsen S et al (2012) Lack of association of OPRM1 and ABCB1 single-nucleotide polymorphisms to oxycodone response in postoperative pain. J Clin Pharmacol 52:234\u2013242","journal-title":"J Clin Pharmacol"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"108914","DOI":"10.1016\/j.cbi.2019.108914","volume":"316","author":"Y Qian","year":"2020","unstructured":"Qian Y, Gilliland TK, Markowitz JS (2020) The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin. Chem Biol Interact 316:108914","journal-title":"Chem Biol Interact"},{"key":"18_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/1096-8628(20001009)96:5<592::AID-AJMG3>3.0.CO;2-Y","volume":"96","author":"BR Lawford","year":"2000","unstructured":"Lawford BR, Young RM, Noble EP et al (2000) The D2 dopamine receptor A1 allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 96:592\u2013598","journal-title":"Am J Med Genet"},{"key":"18_CR57","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2133\/dmpk.DMPK-11-RG-134","volume":"27","author":"Y Takashina","year":"2012","unstructured":"Takashina Y, Naito T, Mino Y et al (2012) Impact of CYP3A5 and ABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system. Drug Metab Pharmacokinet 27:414\u2013421","journal-title":"Drug Metab Pharmacokinet"},{"key":"18_CR58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/FPC.0000000000000032","volume":"24","author":"DT Barratt","year":"2014","unstructured":"Barratt DT, Bandak B, Klepstad P et al (2014) Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenet Genomics 24:185\u2013194","journal-title":"Pharmacogenet Genomics"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/npp.2013.99","volume":"38","author":"RC Crist","year":"2013","unstructured":"Crist RC, Clarke T-K, Ang A et al (2013) An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology 38:2003\u20132010","journal-title":"Neuropsychopharmacology"},{"key":"18_CR60","doi-asserted-by":"publisher","first-page":"599721","DOI":"10.3389\/fphar.2020.599721","volume":"11","author":"C Culp","year":"2021","unstructured":"Culp C, Kim HK, Abdi S (2021) Ketamine use for cancer and chronic pain management. Front Pharmacol 11:599721","journal-title":"Front Pharmacol"},{"key":"18_CR61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jphs.2017.08.006","volume":"135","author":"X Zheng","year":"2017","unstructured":"Zheng X, Fang P, Bao S et al (2017) Function of 38 variants CYP2C9 polymorphism on ketamine metabolism in vitro. J Pharmacol Sci 135:8\u201313","journal-title":"J Pharmacol Sci"},{"key":"18_CR62","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bcp.12614","volume":"80","author":"Y Li","year":"2015","unstructured":"Li Y, Jackson KA, Slon B et al (2015) CYP2B6 * 6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects. Br J Clin Pharmacol 80:276\u2013284","journal-title":"Br J Clin Pharmacol"},{"key":"18_CR63","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.2147\/JPR.S217005","volume":"12","author":"AD Stoker","year":"2019","unstructured":"Stoker AD, Rosenfeld DM, Buras MR et al (2019) Evaluation of clinical factors associated with adverse drug events in patients receiving sub-anesthetic ketamine infusions. J Pain Res 12:3413\u20133421","journal-title":"J Pain Res"},{"key":"18_CR64","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/ACO.0000000000000879","volume":"33","author":"NM Birgenheier","year":"2020","unstructured":"Birgenheier NM, Stuart AR, Egan TD (2020) Soft drugs in anesthesia: remifentanil as prototype to modern anesthetic drug development. Curr Opin Anaesthesiol 33:499\u2013505","journal-title":"Curr Opin Anaesthesiol"},{"key":"18_CR65","first-page":"73","volume":"5","author":"R Landau","year":"2012","unstructured":"Landau R (2012) Pharmacogenomic considerations in opioid analgesia. Pharmgenomics Pers Med 5:73\u201387","journal-title":"Pharmgenomics Pers Med"},{"key":"18_CR66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00228-011-1056-x","volume":"67","author":"C Brasch-Andersen","year":"2011","unstructured":"Brasch-Andersen C, M\u00f8ller MU, Christiansen L et al (2011) A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C). Eur J Clin Pharmacol 67:1131\u20131137","journal-title":"Eur J Clin Pharmacol"},{"key":"18_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.36076\/ppj.2014\/17\/425","volume":"17","author":"AM Trescot","year":"2014","unstructured":"Trescot AM, Faynboym S (2014) A review of the role of genetic testing in pain medicine. Pain Physician 17:425\u2013445","journal-title":"Pain Physician"},{"key":"18_CR68","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE et al (2016) Increases in drug and opioid overdose deaths \u2013 United States, 2000-2014. MMWR Morb Mortal Wkly Rep 64:1378\u20131382","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"18_CR69","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","volume":"54","author":"C Florence","year":"2016","unstructured":"Florence C, Luo F, Xu L et al (2016) The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med Care 54:901\u2013906","journal-title":"Med Care"},{"key":"18_CR70","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0885-3924(94)90175-9","volume":"9","author":"J Faucett","year":"1994","unstructured":"Faucett J, Gordon N, Levine J (1994) Differences in postoperative pain severity among four ethnic groups. J Pain Symptom Manag 9:383\u2013389","journal-title":"J Pain Symptom Manag"},{"key":"18_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11916-000-0006-6","volume":"4","author":"RB Fillingim","year":"2000","unstructured":"Fillingim RB (2000) Sex, gender, and pain: women and men really are different. Curr Rev Pain 4:24\u201330","journal-title":"Curr Rev Pain"},{"key":"18_CR72","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1213\/ANE.0000000000002458","volume":"125","author":"JM Hah","year":"2017","unstructured":"Hah JM, Bateman BT, Ratliff J et al (2017) Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg 125:1733\u20131740","journal-title":"Anesth Analg"},{"key":"18_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.656748","volume":"12","author":"N Neskovic","year":"2021","unstructured":"Neskovic N, Mandic D, Marczi S et al (2021) Different pharmacokinetics of tramadol, O-demethyltramadol and N-demethyltramadol in postoperative surgical patients from those observed in medical patients. Front Pharmacol 12:656748","journal-title":"Front Pharmacol"},{"key":"18_CR74","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41436-018-0431-8","volume":"21","author":"DM Smith","year":"2019","unstructured":"Smith DM, Weitzel KW, Elsey AR et al (2019) CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genet Med 21:1842\u20131850","journal-title":"Genet Med"}],"container-title":["Methods in Molecular Biology","Pharmacogenomics in Drug Discovery and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2573-6_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T04:02:53Z","timestamp":1696478573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2573-6_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071625729","9781071625736"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2573-6_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"7 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}